These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11103419)
1. [Nuclear medicine study potentials in diseases of the skeletal system]. Gratz S; Becker W Radiologe; 2000 Oct; 40(10):953-62. PubMed ID: 11103419 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history. Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199 [TBL] [Abstract][Full Text] [Related]
4. [How does it work? Skeletal scintigraphy]. Hahn K MMW Fortschr Med; 2003 Aug; 145(33-34):64. PubMed ID: 14526589 [No Abstract] [Full Text] [Related]
5. [Bone scintigraphy in modern clinical diagnosis]. Rajtár M Orv Hetil; 1982 Jun; 123(26):1603-8. PubMed ID: 7110708 [No Abstract] [Full Text] [Related]
8. [Current data on skeletal scintigraphy]. Santaniello B; Biassoni P; Bagnasco M Arch Maragliano Patol Clin; 1977; 33():102-14. PubMed ID: 263673 [No Abstract] [Full Text] [Related]
9. Bone scintigraphy. Goldstein HA Orthop Clin North Am; 1983 Jan; 14(1):243-56. PubMed ID: 6338446 [No Abstract] [Full Text] [Related]
10. [Evaluation of bone diseases using dynamic bone scintigraphy]. Kumano M; Tamura K; Hamada T; Ishida O; Kajita A; Ushio K; Okuno T Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Dec; 43(12):1393-406. PubMed ID: 6425801 [No Abstract] [Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
12. Nuclear Medicine in Osteology. 7th Nuclear Medicine Workshop Innsbruck--Hannover 1991. Riccabona G; Hundeshagen H Nuklearmedizin; 1991 Dec; 30(6):297-302. PubMed ID: 1780246 [No Abstract] [Full Text] [Related]
13. [Bone scintigraphy: diagnostic value and indications (author's transl)]. Gaucher A; Colomb JN; Naoun A Nouv Presse Med; 1981 Jan; 10(4):239-42. PubMed ID: 7465360 [TBL] [Abstract][Full Text] [Related]
14. Nonosseous uptake on bone scan in adenocarcinoma of unknown primary origin. Chen X; Jacobson AF Clin Nucl Med; 2000 Sep; 25(9):751-2. PubMed ID: 10983778 [No Abstract] [Full Text] [Related]
15. When to use bone scintigraphy. It can reveal things other studies cannot. Hendler A; Hershkop M Postgrad Med; 1998 Nov; 104(5):54-6, 59-61, 65-6 passim. PubMed ID: 9823385 [TBL] [Abstract][Full Text] [Related]
16. [Guidelines for bone scintigraphy]. Bares R Nuklearmedizin; 1999; 38(6A):251-3. PubMed ID: 10510823 [No Abstract] [Full Text] [Related]
18. [Value of 3-phase skeletal scintigraphy in the diagnosis of bone metastases]. Rieden K; Adolph J; Georgi P; zum Winkel K Rofo; 1987 Aug; 147(2):138-42. PubMed ID: 2819965 [TBL] [Abstract][Full Text] [Related]
19. [Skeletal scintigraphy. Its diagnostic possibilities and indications as compared to x-ray studies]. Bessler W Schweiz Med Wochenschr; 1975 Feb; 105(6):175-80. PubMed ID: 1121663 [TBL] [Abstract][Full Text] [Related]
20. Differentiation of malignant and degenerative bone lesions using dexamethasone interventional 3- and 24-hour bone scintigraphy. Bhatnagar A; Mondal A; Kashyap R; Sharma RK; Sharma R; Chakravarty SK; Bihari V; Sawroop K; Chopra MK; Soni NL Eur J Nucl Med; 1994 Jul; 21(7):609-14. PubMed ID: 7957346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]